Sumit Ghosh
Abigail Wexner Research Institute at Nationwide Children's Hospital, University of North Dakota, North Dakota State University
0000-0002-6890-954X
About
Dr. Sumit Ghosh has received his Bachelors of Technology degree in Biotechnology (Major: Genetic Engineering) from India. He completed his Ph.D. in summer of 2012 in Cellular and Molecular Biology from North Dakota State University. He then continued his postdoctoral work in the field of Immunology at North Dakota State University where he investigated the role of B lymphocytes and Extracellular Matrix Components (ECM) components in allergic fungal asthma. In May 2015, he was hired as the first Biological Safety Officer at the University of North Dakota (UND) to set up their BSL-3 facility. He was as an adjunct faculty at UND where he collaborated with researchers to develop courses in the field of Biological Safety and new co-infection disease model systems. He is a Registered Biosafety Professional and currently serves on the Publication Committee and the Distance Learning Committee of American Biological Safety Association International (ABSA). Additionally, he serves on the editorial board of several national and international journals. He is an trained immunologist and Environmental Health and Safety Leader with extensive experience in Biological Safety, OSHA, EPA, DOT regulations, and in-depth knowledge of high containment labs. He is currently working as the Associate Director of Research Safety/Research Biosafety Officer at the Research Institute at Nationwide Children’s Hospital.
Employment
-
Abigail Wexner Research Institute at Nationwide Children's Hospital Associate Director of Safety/Biosafety Officer2019 - Present
-
University of North Dakota Adjunct Assistant Professor2018 - 2019
-
University of North Dakota Biological Safety Officer2015 - 2019
-
North Dakota State University Postdoctoral Fellow2012 - 2015
Education
-
North Dakota State University Ph.D2007 - 2012
Projects & Funding
Projects & funding information is unavailable.
Publications (48)
- Enhancing Biosafety and Reduction of Injuries in Research Laboratories Through Implementation of Safer Sharps Controls Save
- How Forming a Department-Specific Employee Safety Team Impacted Mitigating Risk and Improving the Safety Culture in an Animal Resources Core Facility Save
- Biosafety Guidelines for Viral Vector-Based Gene Therapies: A Resource for Healthcare and Pharmacy Professionals Save
- A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapies Save
- Detection of Zoonotic Bacteria and Paragonimus kellicotti in Red Swamp Crayfish (Procambarus clarkii) and the Assessment of Traditional Crayfish Boils Save
- Biosafety Practices for In Vivo Viral-Mediated Gene Therapy in the Health Care Setting Save
- Safeguards for Using Viral Vector Systems in Human Gene Therapy: A Resource for Biosafety Professionals Mitigating Risks in Health Care Settings Save
- The Impact of a Risk-Based Mitigation Program on Employee Injuries in Laboratory Animal Facilities. Save
- IL-6 Deficiency Exacerbates Allergic Asthma and Abrogates the Protective Effect of Allergic Inflammation against Streptococcus pneumoniae Pathogenesis Save
- Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges Save